Rhumbline Advisers Nex Immune, Inc. Transaction History

Rhumbline Advisers

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$1.61 - $4.68 $22,541 - $65,524	-14,001 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$1.79 - $4.65 $7,115 - $18,483	3,975 Added 39.65%	14,001 $59,000
Q4 2021 Feb 10, 2022	SELL	$4.11 - $15.13 $1,257 - $4,629	-306 Reduced 2.96%	10,026 $46,000
Q3 2021 Nov 12, 2021	BUY	$10.32 - $16.9 $106,626 - $174,610	10,332 New	10,332 $156,000

Ticker NEXI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,155,600
Market Cap $5.07M
Description
NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform. The company's pr...

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

Stay updated on Rhumbline Advisers with notifications on news.